![Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20171002105054-43413-mediumThumb-S1092852917000608_fig7g.jpg?pub-status=live)
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core
![Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics - Tonini - 2004 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics - Tonini - 2004 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5dba9b05-8e40-424b-b4f4-cd32792ec2c1/apt_1867_f1.gif)
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics - Tonini - 2004 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20171002105054-89843-mediumThumb-S1092852917000608_fig9g.jpg?pub-status=live)
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core
![−)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions - ScienceDirect −)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165614700019295-gr1.jpg)
−)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions - ScienceDirect
![Figure 1 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar Figure 1 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3121dc0d275c4e93aba9b2b6a72278e3d49ffd0e/1-Figure1-1.png)
Figure 1 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar
![Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects | CNS Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects | CNS](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180618081716365-0870:S1092852917000621:S1092852917000621_fig2g.jpeg?pub-status=live)
Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects | CNS
![D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons: Trends in Neurosciences D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons: Trends in Neurosciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/586140/4447025/gr1.jpg)
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons: Trends in Neurosciences
![A schematic drawing of the antiparkinsonian action mechanism of 5-HT 1A... | Download Scientific Diagram A schematic drawing of the antiparkinsonian action mechanism of 5-HT 1A... | Download Scientific Diagram](https://www.researchgate.net/profile/Yukihiro-Ohno/publication/44645355/figure/fig5/AS:601609545478182@1520446301919/Fig-6-A-schematic-drawing-of-the-antiparkinsonian-action-mechanism-of-5-HT-1A.png)
A schematic drawing of the antiparkinsonian action mechanism of 5-HT 1A... | Download Scientific Diagram
![JCI Insight - Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia JCI Insight - Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia](https://df6sxcketz7bb.cloudfront.net/manuscripts/145000/145632/medium/jci.insight.145632.ga.jpg)
JCI Insight - Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia
![Dopamine D2 receptor activator quinpirole protects against trypsinogen activation during acute pancreatitis via upregulating HSP70 | American Journal of Physiology-Gastrointestinal and Liver Physiology Dopamine D2 receptor activator quinpirole protects against trypsinogen activation during acute pancreatitis via upregulating HSP70 | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00354.2019/asset/images/medium/zh3007197784r001.png)